Call for Abstract

7th Asia Pacific STD and Infectious Diseases Congress, will be organized around the theme “Focus on Syndromes and Prognosis of the disease and its complications”

STD Asia Pacific 2017 is comprised of 19 tracks and 218 sessions designed to offer comprehensive sessions that address current issues in STD Asia Pacific 2017.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

STDs (or STIs) are infections that can mostly be passed on to another person during sex, be it anal, oral or vaginal sex. There are different types of STDs, from very benign to malignant and harmful ones. Nearly 20 different infections are known to be transmitted through sexual contact. Most STDs affect both men and women, but in many cases the health problems they cause can be more severe for women. If a pregnant woman has an STD, it can cause serious health problems for the baby. More than 40 types of HPV can be spread sexually. If untreated, STIs can increase your risk of acquiring another STI such as HIV. Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi or parasites and can spread between individuals. There are almost 217 types of infectious diseases among them some are such as 'Common cold' include a number of distinct pathogens. Many infectious diseases, such as measles and chickenpox, can be prevented by vaccines.

  • Track 1-1STIs and HIV/ AIDs
  • Track 1-2Human Papillomavirus (HPV)
  • Track 1-3Syphilis
  • Track 1-4Chlamydia
  • Track 1-5Gonorrhea
  • Track 1-6Genital Herpes
  • Track 1-7Bacterial Vaginosis
  • Track 1-8Trichomoniasis
  • Track 1-9Ectoparasitics and Arthropods
  • Track 1-10Crabs
  • Track 1-11African Trypanosomiasis
  • Track 1-12Fungal, Bacterial, Viral, Parasitic infectious diseases
  • Track 1-13Neuro infectious diseases
  • Track 1-14Air, food, water and blood borne infectious diseases
  • Track 1-15Inflammatory infectious diseases
  • Track 1-16Tropical infectious diseases
  • Track 1-17Infectious diseases during pregnancy
  • Track 1-18Rare infectious diseases
  • Track 1-19Sexually transmitted infectious diseases
  • Track 1-20Pediatric infectious diseases
  • Track 1-21Common infectious diseases
  • Track 1-22Geriatric infectious diseases

Depending on the type of disease, STDs can be spread with any type of sexual activity. STDs are most often caused by viruses and bacteria, both bacterial and viral STDs vary in their treatment. Bacterial STDs, such as gonorrhea, syphilis, and chlamydia, are often cured with antibiotics. However, viral STDs, such as HIV, HPV (genital warts), herpes, and hepatitis (the only STD that can be prevented with a vaccine), have no cure, but their symptoms can be alleviated with treatment. STDs, such as gonorrhea and syphilis, are classified as "reportable" because when diagnosed they must be reported to a proper health or government agency to prevent their spread. Gonorrhea, one of the most widespread of the STDs, is caused by the bacterium Neisseria gonorrhoeae, some strains of which are resistant to treatment by penicillin as well as the other drugs of choice. 80 percent of women and 40 percent of men diagnosed with chlamydia may not experiencesymptoms.

  • Track 2-1Chancroid
  • Track 2-2 Yeast in Men
  • Track 2-3Yeast Infection
  • Track 2-4Vaginosis
  • Track 2-5Mycoplasma Genitalium 
  • Track 2-6Cytomegalovirus (CMV)
  • Track 2-7Scabies
  • Track 2-8Intestinal Parasites
  • Track 2-9Mononucleosis
  • Track 2-10Molluscum Contagiosum
  • Track 2-11Herpes (HSV1 & HSV2)
  • Track 2-12Genital Warts
  • Track 2-13Cytomegalovirus
  • Track 2-14Viral Hepatitis
  • Track 2-15Vaginitis
  • Track 2-16Pelvic Inflammatory Disease (PID)
  • Track 2-17Nongonococcal Urethritis (NGU)
  • Track 2-18Lymphogranuloma Venereum (LGV)
  • Track 2-19Epstein Barr virus

STDs often have no signs or symptoms (asymptomatic). Understanding the risks and knowing the signs and symptoms of common STDs in men is crucial for any man who is sexually active. Female symptoms of an STD can include vaginal itching, rashes, unusual discharge, and pain, though many women have no symptoms. STDs can lead to fertility problems and an increased risk of cervical cancer if left untreated. These risks make it even more important to practice safe sex. This happens because an STI can stimulate an immune response in the genital area or cause sores, either of which might raise the risk of HIV transmission. The signs and symptoms usually disappear within a week to a month and are often mistaken for those of another viral infection. More-persistent or severe symptoms of HIV infection may not appear for 10 years or more after the initial infection.

  • Track 3-1HIV & Retro Virus
  • Track 3-2Symptoms and diagnosis
  • Track 3-3Risks and Resiliencies
  • Track 3-4Human papillomavirus (HPV) infection 
  • Track 3-5PID (Pelvic Inflammatory Disease)
  • Track 3-6UTI’s (Urinary Tract Infections)
  • Track 3-7Herpes and HIV acquisition
  • Track 3-8HIV Molecular and Serology
  • Track 3-9Anti-Retroviral therapy & drugs
  • Track 3-10Genital microbiome and HIV transmission
  • Track 3-11Treatments, prevention and management

Since 1993, STI epidemiology and management have evolved interactively, particularly in developing countries. Technological advances in diagnosis, screening, and treatment; evaluation and widespread implementation of new case-management algorithms; and changes in risk behaviors in response to the AIDS epidemic have all influenced the dynamic typology of STIs. Every year worldwide, there are approximately 357 million new infections of syphilis, chlamydia, gonorrhea, and trichomoniasis. A major recent advance in STI prevention is the early success of a prophylactic, monovalent human papillomavirus (HPV) type 16 vaccine, HPV vaccines may be able to help prevent genital and anal cancers in the foreseeable future.

  • Track 4-1Syndromic Management
  • Track 4-2Role of Core Groups
  • Track 4-3Antibiotic Use
  • Track 4-4Drug Resistance
  • Track 4-5Sexual Health Care
  • Track 4-6Social Risk Markers
  • Track 4-7Behavioral Risk Factors
  • Track 4-8Clinical interventions 

Syphilis is a sexually transmitted disease (STD) that can have very serious complications when left untreated, but it is simple to cure with the right treatment. Symptoms in adults are divided into stages. These stages are primary, secondary, latent, and late syphilis. Syphilis can be spread by direct contact with a syphilis sore during vaginal, anal, or oral sex. Sores can be found on the penis, vagina, anus, in the rectum, or on the lips and in the mouth. Syphilis has been called ‘the great imitator’ because it has so many possible symptoms, many of which look like symptoms from other diseases. The painless syphilis sore that you would get after you are first infected can be confused for an ingrown hair, zipper cut, or other seemingly harmless bump. A syphilis infected baby may be born without signs or symptoms of disease. However, if not treated immediately, the baby may develop serious problems within a few weeks. Untreated babies can have health problems such as cataracts, deafness, or seizures, and can die.

  • Track 5-1Primary syphilis
  • Track 5-2Secondary syphilis
  • Track 5-3Latent syphilis
  • Track 5-4Tertiary syphilis
  • Track 5-5congenital syphilis
  • Track 5-6Neurosyphilis
  • Track 5-7Miscarriage/Stillbirth
  • Track 5-8Blindness/Stroke

Exposure of susceptibles to infected individuals can be influenced through counseling of patients to reduce early sexual debut and concurrent sexual partners, and to promote the performance of safer sexual activities, including:

·         Nonpenetrative sexual acts,

·         Consistent and correct use of condom, and

·         STI and HIV testing followed by commitment to monogamy.

Efficiency of transmission during exposure between susceptible and infectious partners can be influenced by a number of primary care physician interventions. Advising patients to use “safer sex” practices such as condom and avoidance of unprotected vaginal or anal intercourse can substantially reduce the transmission of some STI pathogens. The application of epidemiologic treatment to patients who have had a known exposure to a STI can reduce transmission presumably by treating patients either before symptoms develop or during the incubation period of the infection. Other forms of post- exposure prophylaxis have been also been used to prevent HIV infection following needle - stick, or sexual assault exposure. Finally, physicians can reduce the infectivity of some infected individuals by the use of suppressive antimicrobial therapy.

  • Track 6-1Chronic Lifestyle Changes
  • Track 6-2Immunodeficiency
  • Track 6-3STI Viral Pathoges
  • Track 6-4Incubation period of the infection
  • Track 6-5Post-exposure prophylaxis
  • Track 6-6Suppressive antimicrobial therapy
  • Track 6-7Efficiency Of Transmission
  • Track 6-8Haematological Diagnosis

Women who are pregnant can become infected with the same STDs as women who are not pregnant. Pregnancy does not provide women or their babies any additional protection against STDs. STDs can complicate the pregnancy and may have serious effects on both mother and the developing baby. STDs/STIs during pregnancy can also cause Miscarriage, Ectopic pregnancy, Preterm labor and delivery, Birth defects and Newborn death etc. Some of these problems may be seen at birth; others may not be discovered until months or years later. Testing and treating pregnant women for STDs is a vital way to prevent serious health complications to both mother and baby that may otherwise happen with infection. STDs, such as chlamydia, gonorrhea, syphilis, trichomoniasis and BV can all be treated and cured with antibiotics that are safe to take during pregnancy.

  • Track 7-1Types of STDs in pregnancy
  • Track 7-2Embryo/fetus affect
  • Track 7-3STDs affect in pregnancy
  • Track 7-4Risk of transmission
  • Track 7-5Antibiotics Treatment
  • Track 7-6Abstain
  • Track 7-7Antiviral medications
  • Track 7-8Antimicrobial drugs

The syndromic approach is an important tool in the control of STIs and their sequelae, management by syndrome alone is inadequate because infections with important pathogens such as Chlamydia trachomatis and Neisseria gonorrhoeae may be present without any symptoms or findings. It is crucial to recognize syndromes that may be caused by one or more sexually transmitted pathogens and in managing STIs, diagnosis by syndrome and laboratory diagnosis by testing for specific organisms are both important and complementary. Diagnosis of a syndrome according to standard criteria predicts the likelihood that a specific pathogen or pathogens is/are present and thus facilitates initiation of appropriate empiric treatment at the first visit rather than deferring treatment until there is microbiological confirmation. WHO has developed simple flowcharts (also called algorithms) to guide health care providers in using the syndromic approach to manage seven syndromes.

  • Track 8-1Sexually transmitted infection(STI)-related enteric infections
  • Track 8-2Cervicitis(Inflammation of Cervix)
  • Track 8-3Urethritis(Inflammation of Urethra)
  • Track 8-4Pelvic Inflammatory Disease
  • Track 8-5Hepatitis(Inflammation of Liver)
  • Track 8-6Prostatitis(Inflammation of Prostate)
  • Track 9-1Acute and chronic infections
  • Track 9-2Pediatric infection control
  • Track 9-3Pediatric and adolescent HIV disease
  • Track 9-4Congenital and perinatal infections
  • Track 9-5Antibiotic stewardship in pediatrics
  • Track 9-6Blood infections
  • Track 9-7Pediatric Tuberculosis
  • Track 9-8Pediatric parasitic diseases
  • Track 9-9Pediatric tropical diseases
  • Track 9-10Vaccine preventable diseases

Abnormal development of the fetus resulting in death, malformation, growth retardation, and functional disorders is defined as birth defects. Approximately 150,000 babies are born each year with birth defects. Birth defects, including low birth weight babies, are the leading cause of infant mortality. Chlamydia, among the most common sexually transmitted diseases, affects an estimated 100,000 pregnant women each year, according to the Centers for Disease Control and Prevention. In fact, it's one of the leading causes of infections affecting newborns' eyes and respiratory system. Exposure to the bacteria during childbirth could lead to infection of the respiratory tract, causing infant pneumonia. While some types of birth defects have decreased, mainly through preventive methods, many have increased. According to a CDC study of 38 types of birth defects occurring over the period 1979-89, 27 had increased, including several cardiac defects, chromosomal defects such as trisomy 18, and fetal alcohol syndrome; 9 had remained the same; and only 2 had decreased.

  • Track 10-1Chromosomal abnormalities
  • Track 10-2Genetic disorder
  • Track 10-3Mental retardation
  • Track 10-4Poor growth
  • Track 10-5Premature birth
  • Track 10-6Altered metabolism
  • Track 10-7Affect of teratogens
  • Track 10-8Functional abnormality
  • Track 10-9Mutations
  • Track 10-10Low birth weight

Having an STD/STI increases a person's risk for several types of cancer. Certain high-risk types of human papillomavirus (HPV) can cause cervical cancer in women and other cancers including cancer of the vulva, vagina. In men, HPV infection can lead to the development of penile cancers. HPV also can cause cancers of the mouth, throat, and anus in both sexes. It can also cause oropharyngeal cancer. Acquiring viral hepatitis B or C puts a person at risk for liver cancer, and untreated HIV/AIDS increases risk for several types of rare cancers, including lymphomas, sarcomas, and cervical cancer. There are HPV tests that can be used to screen for cervical cancer. These tests are recommended for screening only in women aged 30 years and older. They are not recommended to screen men, adolescents, or women under the age of 30 years.

  • Track 11-1Cervical cancer
  • Track 11-2Prostate Cancer
  • Track 11-3Head and Neck cancer
  • Track 11-4Sarcomas
  • Track 11-5Oropharyngeal cancer
  • Track 11-6Vulva, Vagina cancers
  • Track 11-7Lymphomas
  • Track 11-8Liver cancer(hepatitis B or C)
  • Track 11-9Mouth and Throat cancers
  • Track 11-10Penile cancers
  • Track 11-11Gastric Cancer

Sexually transmitted Infections (STIs) rank among the most important health issues for the people especially the young adults worldwide. The development of educational programs will play vital role in the fight to control sexually transmitted diseases. The Sexually Transmitted Disease (STD) infection prevention and control program works to reduce the incidence of sexually transmitted diseases. Social media practices to help implement awareness strategies. Awareness was generally high for HIV/AIDS (above 90%) and low for HPV (range 5.4%-66%). By providing screening, testing, diagnosis and treatment for infected individuals, the STD program is fighting the war against sexually transmitted diseases one person at a time. STDs can be simply prevented with three actions (a) Talk openly to partners, patients, and healthcare providers about sexual health and STDs, (b) Ensure everyone knows who should be tested and when, (c) The important role healthcare providers and patients play in making sure STDs are treated correctly.

  • Track 12-1Use of condom
  • Track 12-2safe sex
  • Track 12-3Educational programs
  • Track 12-4Avoid intravenous drugs
  • Track 12-5Clinical training
  • Track 12-6Screening Recommendations
  • Track 12-7Advanced treatments
  • Track 12-8Implement strategies
  • Track 12-9Lifestyle and home remedies

Sexually transmitted diseases(STDs) remain a major public health challenge in the world. Biological factors place women at greater risk than men for the severe health consequences of STDs. The two most commonly reported infectious diseases in America is chlamydia and gonorrhea which pose a particular risk to the health of women, as both can result in infertility if left untreated. Trends of STD are more toward viral origin as compare to bacterial origin. Epidemiology helped to develop methodology used in clinical research, public health studies and to a lesser extent basic research in the biological sciences

  • Track 13-1Chemicals and bulk drugs development
  • Track 13-2Molecular diagnostics
  • Track 13-3Filter media
  • Track 13-4Disinfection equipments
  • Track 13-5Nano materials
  • Track 13-6Testing tools
  • Track 13-7Drug formulation devices
  • Track 13-8Devices and instruments
  • Track 13-9Pharmaceuticals
  • Track 13-10Modelling of infectious diseases

Most healthy people’s immune systems kill or contain TB infection without developing symptoms. Latent TB infection is an asymptomatic and non-transmissible form of TB. Hepatitis is an inflammation of the liver. There are 5 main hepatitis viruses, referred to as types A, B, C, D and E. Twin studies of tuberculosis (TB) and chronic hepatitis B virus (HBV) infection identified a strong host genetic component to individual variability in disease susceptibility. Short-course chemotherapy containing rifampicin and isoniazid in combination has proved to be highly effective in the treatment of tuberculosis, but one of its adverse effects is hepatotoxicity. An estimated 49 million lives were saved through TB diagnosis and treatment between 2000 and 2015. 

  • Track 14-1Tuberculosis and STD
  • Track 14-2Liver disorders
  • Track 14-3Auto immune hepatitis
  • Track 14-4Hepatic cirrhosis
  • Track 14-5Chronic hepatitis
  • Track 14-6Hepatitis C Coalition
  • Track 14-7Acute hepatitis
  • Track 14-8Types of hepatits
  • Track 14-9 Risk Factors
  • Track 14-10Tuberculosis in children
  • Track 14-11Pulmonary/Extrapulmonary TB 
  • Track 14-12Hepatotoxicity
  • Track 14-13Tuberculosis - Health impact
  • Track 14-14Prevalence
  • Track 14-15TB and HIV coinfection
  • Track 14-16Causes, Symptoms and Treatments

Infectious diseases prevention and control is helpful to prevent the transmission of infectious diseases. STI control efforts have increasingly been defined in relation to HIV programme priorities that are funded, implemented and evaluated independently of other STI control efforts. STI control is a public health outcome, measured as reduced incidence and prevalence, achieved by implementing strategies composed of multiple synergistic interventions. 

  • Track 15-1Treatment for infections
  • Track 15-2Alternative therapies
  • Track 15-3"The Lowdown" Infographic
  • Track 15-4Mutual Monogamy
  • Track 15-5Reduce Number of Sex Partners
  • Track 15-6Abstinence
  • Track 15-7Good hygienic practices
  • Track 15-8Diagnosis of infectious diseases
  • Track 15-9Tuberculosis, Hepatitis and Malaria treatment and cure
  • Track 15-10Ebola and Zika viral infections diagnosis and cure
  • Track 15-11STDS, STIS and HIV/ AIDS prevention and control
  • Track 15-12Infection control and cure
  • Track 15-13Targeting high-risk populations

Some STDs, such as such as gonorrhea, Chlamydia, and syphilis, are caused by bacteria. They are usually effectively treated with antibiotics. Several STDs can be effectively prevented through pre-exposure vaccination with widely available vaccines, including HAV, HBV, and HPV. Viral STDs are often highly persistent despite current therapeutic options or have no acceptable treatment available. Therefore, vaccines for certain viral STDs are in use, and others are in development.

  • Track 16-1HPV Vaccines
  • Track 16-2Gonorrhea and Chlamydia vaccines
  • Track 16-3Tetanus vaccine
  • Track 16-4Polio vaccine
  • Track 16-5Mumps vaccine
  • Track 16-6Varicella vaccine
  • Track 16-7Diphtheria vaccine
  • Track 16-8AIDS and Retroviral vaccines
  • Track 16-9Tick-Borne Encephalitis vaccines
  • Track 16-10Tuberculosis (BCG Vaccine)
  • Track 16-11Varicella (chickenpox) vaccine
  • Track 16-12Influenza (flu) vaccine
  • Track 16-13Hepatitis A & B vaccine
  • Track 16-14HIV vaccines
  • Track 16-15Genital Herpes vaccine
  • Track 16-16Hepatitis B vaccine
  • Track 16-17Genital Herpes vaccines

With the newer diagnostic technologies, we are on the verge of a major change in the approach to STI control. When diagnostic methods are faster and results more accurate, they are bound to improve patient care. The molecular techniques are useful for microorganisms that are difficult to culture. They have a fairly recent history of just over 40 years. They are increasingly being accepted by clinicians as viable options in their practice. Aseptic technique is normally applied to prevent the infections caused by different means.

  • Track 17-1Molecular techniques
  • Track 17-2Pharmaceutical design of Drug and mechanism
  • Track 17-3Stem cell therapy
  • Track 17-4Antiviral drugs
  • Track 17-5Anti-Retroviral (ARV) Therapies and Vaccination
  • Track 17-6PER.C6 technology
  • Track 17-7AdVac  Technology

The sexually transmitted diseases Testing Market is forecast to reach $167.4 billion by 2020, registering a CAGR of 8.5% during 2014-2020. STDs are a grave issue globally, and are responsible for high morbidity in adults and cause infertility in both men and women. Diagnostic procedures of STDs market include the technologies that are used to identify and analyze STD along with the laboratories where the tests are carried out. Diagnostic testing programs are implemented by health care departments in developed regions for prevention and control of transmission, specifically of P&S Syphilis, Chlamydia, Gonorrhea and HPV. HPV testing volume and revenue will grow at much faster rate owing to higher incidences in Asia Pacific region.

  • Track 18-1Blood/Serum testing 
  • Track 18-2CSF examination
  • Track 18-3testing types of STDs
  • Track 18-4CICT/PICT testing
  • Track 18-5Absorbance microplate reader
  • Track 18-6Rapid diagnostic kits
  • Track 18-7Phone chips
  • Track 18-8Differential Light Scattering machines
  • Track 18-9Flow Cytometers
  • Track 18-10Immunochromatographic assays
  • Track 18-11POC testing
  • Track 18-12PCR testing
  • Track 18-13Whiff test

HIV infection can be diagnosed by serologic tests that detect antibodies against HIV-1 and HIV-2 and by virologic tests that can detect HIV antigens or ribonucleic acid (RNA).Treatment for STDs should be screened for HIV infection. Women should be screened annually for cervical cancer precursor lesions by cervical Pap tests. Gonorrhea and chlamydia are bacterial STDs/STIs that can be treated with antibiotics given either orally or by injection. Successful treatment for cancroid cures the infection, resolves the clinical symptoms, and prevents transmission to others.

  • Track 19-1Neurosyphilis diagnostics
  • Track 19-2Gemifloxacin
  • Track 19-3Legal status of EPT
  • Track 19-4Bicillin-LA (benzathine penicillin G)
  • Track 19-5Gonorrhea guidance
  • Track 19-6Expedited Partner Therapy
  • Track 19-7Antibiotic treatment
  • Track 19-8Detection of antibodies
  • Track 19-9Novel approaches
  • Track 19-10Frequent screening
  • Track 19-11Molecular diagnostic
  • Track 19-12Procaine Penicillin G